This seems to be reflective of an upregulation of the whole Gln metabolic pathway, as these Gln-sensitive breast cancer cell lines are also more sensitive to drugs inhibiting this pathway such as aminotransferase inhibitors39 or glutaminase inhibitors.6 Here, GLS is linked to breast cancer.